Blaskovich; Mark Arnold Thomas

Patent Applications and Registrations

Patent applications and USPTO patent grants for Blaskovich; Mark Arnold Thomas.The latest application filed is for "methods of modulating the activity of the mc1 receptor and treatment of conditions related to this receptor".

Company Profile

0.9.9

Blaskovich; Mark Arnold Thomas - Bardon AU
Blaskovich; Mark Arnold Thomas - Bardon QSLD AU
Blaskovich; Mark Arnold Thomas - Queensland N/A AU

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods of modulating the activity of the MC5 receptor and treatment of conditions related to this receptor Grant 9,340,517 - Blaskovich , et al. May 17, 2	2016-05-17
Methods Of Modulating The Activity Of The Mc1 Receptor And Treatment Of Conditions Related To This Receptor App 20140128380 - Blaskovich; Mark Arnold Thomas ; et al.	2014-05-08
Methods Of Modulating The Activity Of The Mc5 Receptor And Treatment Of Conditions Related To This Receptor App 20130225563 - Blaskovich; Mark Arnold Thomas ; et al.	2013-08-29
3-substituted-1,4-diazepan-2-one melanocortin-5 receptor antagonists Grant 8,440,653 - Blaskovich , et al. May 14, 2	2013-05-14
Methods of modulating the activity of the MC5 receptor and treatment of conditions related to this receptor Grant 8,377,925 - Blaskovich , et al. February 19, 2	2013-02-19
3-aminoalkyl-1,4-diazepan-2-one melanocortin-5-receptor antagonists Grant 8,343,958 - Blaskovich , et al. January 1, 2	2013-01-01
Methods Of Modulating The Activity Of The Mc1 Receptor And Treatment Of Conditions Related To This Receptor App 20120141392 - Blaskovich; Mark Arnold Thomas ; et al.	2012-06-07
3-aminoalkyl-1,4-diazepan-2-one Melanocortin-5-receptor Antagonists App 20110263572 - Blaskovich; Mark Arnold Thomas ; et al.	2011-10-27
3-aminoalkyl-1,4-diazepan-2-one melanocortin-5 receptor antagonists Grant 8,008,291 - Blaskovich , et al. August 30, 2	2011-08-30
Protein tyrosine phosphatase inhibitors and methods of use thereof Grant 7,829,737 - Blaskovich , et al. November 9, 2	2010-11-09
Methods Of Modulating The Activity Of The Mc5 Receptor And Treatment Of Conditions Related To This Receptor App 20090221558 - Blaskovich; Mark Arnold Thomas ; et al.	2009-09-03
3-aminoalkyl-1,4-diazepan-2-one Melanocortin-5 Receptor Antagonists App 20090221557 - Blaskovich; Mark Arnold Thomas ; et al.	2009-09-03
Protein Tyrosine Phosphatase Inhibitors And Methods Of Use Thereof App 20090131374 - Blaskovich; Mark Arnold Thomas ; et al.	2009-05-21
Protein tyrosine phosphatase inhibitors and methods of use thereof Grant 7,504,389 - Blaskovich , et al. March 17, 2	2009-03-17
Protein Tyrosine Phosphatase Inhibitors And Methods Of Use Thereof App 20080161592 - Blaskovich; Mark Arnold Thomas ; et al.	2008-07-03
Protein tyrosine phosphatase inhibitors and methods of use thereof App 20060142250 - Blaskovich; Mark Arnold Thomas ; et al.	2006-06-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.